Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC

Blueprint Medicines Corporation · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
carcinomalung-neoplasmsneoplasms
lung neoplasms, carcinoma, non-small-cell lung, respiratory tract neoplasms, neoplasms, neoplasms by site, lung diseases, respiratory tract disease, carcinoma, bronchogenic, bronchial neoplasms, adenocarcinoma, carcinoma, neoplasms by histologic type
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 904535
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.